A novel long noncoding RNA AK001796 acts as an oncogene and is involved in cell growth inhibition by resveratrol in lung cancer

Toxicology and Applied Pharmacology

Volumn 285, Issue 2, 2015, Pages 79-88

  Yang, Qiaoyuan ^a   Xu, Enwu ^b   Dai, Jiabin ^a   Liu, Binbin ^a   Han, Zhiyuan ^a   Wu, Jianjun ^a   Zhang, Shaozhu ^a   Peng, Baoying ^a   Zhang, Yajie ^a   Jiang, Yiguo ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

AK001796; Cancer chemoprevention; Long noncoding RNA; Lung cancer; Lung carcinogenesis; Resveratrol

Indexed keywords

LONG NONCODING RNA AK001796; LONG UNTRANSLATED RNA; RESVERATROL; UNCLASSIFIED DRUG; GROWTH INHIBITOR; STILBENE DERIVATIVE;

A549 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG CARCINOGENESIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; UPREGULATION; ANIMAL; CELL CYCLE; CELL DIVISION; DRUG EFFECTS; DRUG SCREENING; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; LUNG NEOPLASMS; NUDE MOUSE; ONCOGENE; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

ANIMALS; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; DOWN-REGULATION; GENETIC VECTORS; GROWTH INHIBITORS; HUMANS; LUNG NEOPLASMS; MICE, NUDE; MICROARRAY ANALYSIS; ONCOGENES; RNA INTERFERENCE; RNA, LONG NONCODING; STILBENES; TRANSFECTION; TUMOR STEM CELL ASSAY;

EID: 84928103017     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2015.04.003     Document Type: Article

References (49)

1. Aluyen J.K., Ton Q.N., Tran T., Yang A.E., Gottlieb H.B., Bellanger R.A. Resveratrol: potential as anticancer agent. J. Diet Suppl. 2012, 9(1):45-56.
2. Athar M., Back J.H., Kopelovich L., Bickers D.R., Kim A.L. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol. Appl. Pharmacol. 2007, 224:274-283.
3. Athar M., Back J.H., Kopelovich L., Bickers D.R., Kim A.L. Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms. Arch. Biochem. Biophys. 2009, 486(2):95-102.
4. Bae S., Lee E.M., Cha H.J., Kim K., Yoon Y., Lee H., Kim J., Kim Y.J., Lee H.G., Jeung H.K., Min Y.H., An S. Resveratrol alters microRNA expression profiles in A549 human non-small cell lung cancer cells. Mol. Cells 2011, 32(3):243-249.
5. Bishayee A. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev. Res. 2009, 2(5):409-418.
6. Cheetham S.W., Gruhl F., Mattick J.S., Dinger M.E. Long noncoding RNAs and the genetics of cancer. Br. J. Cancer 2013, 108(12):2419-2425.
7. Cimino S., Sortino G., Favilla V., Castelli T., Madonia M., Sansalone S., Russo G.I., Morgia G. Polyphenols: key issues involved in chemoprevention of prostate cancer. Oxidative Med. Cell. Longev. 2012, 2012:632959.
8. Clark M.B., Amaral P.P., Schlesinger F.J., Dinger M.E., Taft R.J., Rinn J.L., Ponting C.P., Stadler P.F., Morris K.V., Morillon A., Rozowsky J.S., Gerstein M.B., Wahlestedt C., Hayashizaki Y., Carninci P., Gingeras T.R., Mattick J.S. The reality of pervasive transcription. PLoS Biol. 2011, 9(7). e1000625.
9. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011, 12(12):861-874.
10. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., Tsai M.C., Hung T., Argani P., Rinn J.L., Wang Y., Brzoska P., Kong B., Li R., West R.B., van de Vijver M.J., Sukumar S., Chang H.Y. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464(7291):1071-1076.
11. Gupta S.C., Kannappan R., Reuter S., Kim J.H., Aggarwal B.B. Chemosensitization of tumors by resveratrol. Ann. N. Y. Acad. Sci. 2011, 1215:150-160.
12. Guttman M., Amit I., Garber M., French C., Lin M.F., Feldser D., Huarte M., Zuk O., Carey B.W., Cassady J.P., Cabili M.N., Jaenisch R., Mikkelsen T.S., Jacks T., Hacohen N., Bernstein B.E., Kellis M., Regev A., Rinn J.L., Lander E.S. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009, 458(7235):223-227.
13. Guttman M., Donaghey J., Carey B.W., Garber M., Grenier J.K., Munson G., Young G., Lucas A.B., Ach R., Bruhn L., Yang X., Amit I., Meissner A., Regev A., Rinn J.L., Root D.E., Lander E.S. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 2011, 477(7364):295-300.
14. Han Z., Yang Q., Liu B., Wu J., Li Y., Yang C., Jiang Y. MicroRNA-622 functions as a tumor suppressor by targeting K-Ras and enhancing the anticarcinogenic effect of resveratrol. Carcinogenesis 2012, 33(1):131-139.
15. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100(1):57-70.
16. Hu Y., Rahlfs S., Mersch-Sundermann V., Becker K. Resveratrol modulates mRNA transcripts of genes related to redox metabolism and cell proliferation in non-small-cell lung carcinoma cells. Biol. Chem. 2007, 388(2):207-219.
17. Huang Y., Sramkoski R.M., Jacobberger J.W. The kinetics of G2 and M transitions regulated by B cyclins. PLoS One 2013, 8(12):e80861.
18. Huarte M., Guttman M., Feldser D., Garber M., Koziol M.J., Kenzelmann-Broz D., Khalil A.M., Zuk O., Amit I., Rabani M., Attardi L.D., Regev A., Lander E.S., Jacks T., Rinn J.L. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010, 142(3):409-419.
19. Hung T., Wang Y., Lin M.F., Koegel A.K., Kotake Y., Grant G.D., Horlings H.M., Shah N., Umbricht C., Wang P., Wang Y., Kong B., Langerød A., Børresen-Dale A.L., Kim S.K., van de Vijver M., Sukumar S., Whitfield M.L., Kellis M., Xiong Y., Wong D.J., Chang H.Y. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat. Genet. 2011, 43(7):621-629.
20. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61(2):69-90.
21. Ji P., Diederichs S., Wang W., Böing S., Metzger R., Schneider P.M., Schneider P.M., Tidow N., Brandt B., Buerger H., Bulk E., Thomas M., Berdel W.E., Serve H., Müller-Tidow C. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22(39):8031-8041.
22. Jiang Y., Chen J., Chen X. Malignant transformation of human bronchial epithelial cells induced by benzo(a)pyrene metabolite dihydroxyepoxy benzo pyrene. Wei Sheng Yan Jiu 2001, 30(3):129-131.
23. Kaur M., Agarwal C., Agarwal R. Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products. J. Nutr. 2009, 139(9):1806S-1812S.
24. Khalil A.M., Guttman M., Huarte M., Garber M., Raj A., Rivea Morales D., Thomas K., Presser A., Bernstein B.E., van Oudenaarden A., Regev A., Lander E.S., Rinn J.L. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(28):11667-11672.
25. Li Y., Kong D., Wang Z., Sarkar F.H. Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharm. Res. 2010, 27(6):1027-1041.
26. Mercer T.R., Dinger M.E., Mattick J.S. Long non-coding RNAs; insights into functions. Nat. Rev. Genet. 2009, 10(3):155-159.
27. Mohammad F., Pandey G.K., Mondal T., Enroth S., Redrup L., Gyllensten U., Kanduri C. Long noncoding RNA-mediated maintenance of DNA methylation and transcriptional gene silencing. Development 2012, 139(15):2792-2803.
28. Müller-Tidow C., Diederichs S., Thomas M., Serve H. Genome-wide screening for prognosis-predicting genes in early-stage non-small-cell lung cancer. Lung Cancer 2004, 45(Suppl. 2):S145-S150.
29. Oak C.H., Wilson D., Lee H.J., Lim H.J., Park E.K. Potential molecular approaches for the early diagnosis of lung cancer. Mol. Med. Rep. 2012, 6(5):931-936.
30. Park K.K., Deok, Ahn J., Lee I.K., Magae J., Heintz N.H., Kwak J.Y., Lee Y.C., Cho Y.S., Kim H.C., Chae Y.M., Ho Kim Y., Kim C.H., Chang Y.C. Inhibitory effects of novel E2F decoy oligodeoxynucleotides on mesangial cell proliferation by coexpression of E2F/DP. Biochem. Biophys. Res. Commun. 2003, 308(4):689-697.
31. PfafflM W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29(9):e45.
32. Prensner J.R., Chinnaiyan A.M. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011, 1(5):391-407.
33. Puliyappadamba V.T., Wu W., Bevis D., Zhang L., Polin L., Kilkuskie R., Finley R.L., Larsen S.D., Levi E., Miller F.R., Wali A., Rishi A.K. Antagonists of anaphase-promoting complex (APC)-2-cell cycle and apoptosis regulatory protein (CARP)-1 interaction are novel regulators of cell growth and apoptosis. J. Biol. Chem. 2011, 286(44):38000-38017.
34. Quoc Trung L., Espinoza J.L., Takami A., Nakao S. Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibition. PLoS One 2013, 8(1):e55183.
35. Ratan H.L., Steward W.P., Gescher A.J., Mellon J.K. Resveratrol-a prostate cancer chemopreventive agent?. Urol. Oncol. 2002, 7(6):223-227.
36. Rinn J.L., Chang H.Y. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 2012, 81:145-166.
37. She J., Yang P., Hong Q., Bai C. Lung cancer in China: challenges and interventions. Chest 2013, 143(4):1117-1126.
38. Shen D.Y., Zhan Y.H., Wang Q.M., Rui G., Zhang Z.M. Oncogenic potential of cyclin kinase subunit-2 in cholangiocarcinoma. Liver Int. 2013, 33(1):137-148.
39. Shih A., Zhang S., Cao H.J., Boswell S., Wu Y.H., Tang H.Y., Lennartz M.R., Davis F.B., Davis P.J., Lin H.Y. Inhibitory effect of epidermal growth factor on resveratrol-induced apoptosis in prostate cancer cells is mediated by protein kinase C-α. Mol. Cancer Ther. 2004, 3(11):1355-1363.
40. Silva J.M., Perez D.S., Pritchett J.R., Halling M.L., Tang H., Smith D.I. Identification of Long stress-induced non-coding transcripts that have altered expression in cancer. Genomics 2010, 95(6):355-362.
41. Silva J.M., Boczek N.J., Berres M.W., Ma X., Smith D.I. LSINCT5 is overexpressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol. 2011, 8(3):496-505.
42. Spizzo R., Almeida M.I., Colombatti A., Calin G.A. Long non-coding RNAs and cancer: a new frontier of translational research?. Oncogene 2012, 31(43):4577-4587.
43. Tano K., Mizuno R., Okada T., Rakwal R., Shibato J., Masuo Y., Ijiri K., Akimitsu N. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett. 2010, 584(22):4575-4580.
44. Tsai M.C., Manor O., Wan Y., Mosammaparast N., Wang J.K., Lan F., Shi Y., Segal E., Chang H.Y. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329(5992):689-693.
45. Tsai M.C., Spitale R.C., Chang H.Y. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 2011, 71(1):3-7.
46. Whyte L., Huang Y.Y., Torres K., Mehta R.G. Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. Cancer Res. 2007, 67(24):12007-12017.
47. Wilusz J.E., Sunwoo H., Spector D.L. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009, 23(13):1494-1504.
48. Yang L., Parkin D.M., Li L.D., Chen Y.D., Bray F. Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br. J. Cancer 2004, 90(11):2157-2166.
49. Yu Y.H., Chen H.A., Chen P.S., Cheng Y.J., Hsu W.H., Chang Y.W., Chen Y.H., Jan Y., Hsiao M., Chang T.Y., Liu Y.H., Jeng Y.M., Wu C.H., Huang M.T., Su Y.H., Hung M.C., Chien M.H., Chen C.Y., Kuo M.L., Su J.L. MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Oncogene 2013, 32(4):431-443.